Every AI newsletter,Guosheng Securities issued a research report on August 13, stating that WuXi AppTec (603259.SH, latest price: 141.44 yuan) buy rating is maintained. The reasons for the rating mainly include: 1) The integrated platform empowers the world, and the quarterly growth demonstrates its strength; 2) The overall investment layout increases, leading the new era of CRDMO. Risk warning: The global epidemic continues to affect business operation risks, the risk of declining demand for pharmaceutical R&D services, the risk of intensified market competition, the risk of loss of core technical personnel, and the risk of exchange rate changes.
AI comment: WuXi AppTec has received the attention of 13 brokerage research reports in the past month, and bought 12 companies with an average target price of 196.5 yuan, which is 55.06 yuan higher than the latest price of 141.44 yuan, and the target average price has increased by 38.93%.
Every Jing Toutiao (nbdtoutiao)——With 80,000 undocumented institutions and 100,000 undocumented personnel, public hospitals have been squeezed out, how long can the story of the high growth of the medical aesthetics industry be told?
(Reporter Cai Ding)
Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. According to this operation, at your own risk.
Copyright Notice
1This article is the original work of “Daily Economic News”.
2
Without the authorization of “Daily Economic News”, it may not be used in any way, including but not limited to reprinting, extracting, copying or creating mirror images, etc., offenders must be investigated.
3Copyright cooperation telephone: 021-60900099.